{"data":{"id":"us/21-cfr-201.116","jurisdiction":"us","citation":"21 CFR 201.116","heading":"Drugs having commonly known directions.","body":"A drug shall be exempt from section 502(f)(1) of the act insofar as adequate directions for common uses thereof are known to the ordinary individual.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 201—LABELING","Subpart D—Exemptions From Adequate Directions for Use"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"2b85d4f399bd56e56572f381828d64bb3ea2c6cea1471727fa67dc98949f7181","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-201.115","next":"us/21-cfr-201.117"},"notice":"GroundRules: Original legal text. Not legal advice."}